Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Pixazo Launches Agent P, a Conversational AI That Turns Plain-Language Requests into Finished Creative Work
-
TransUnion Unveils Transaction Matching to Help Merchants Recognize More Customers
-
New PetScreening Report Shows Pets Are Reshaping Everyday Consumer Decisions
-
Alternative IQ Announces Winners of the 2026 Canadian Hedge Fund Awards
-
Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained Clinical Benefit of Miv-cel in Stiff Person Syndrome at MS Toronto
-
Coppernico Announces Upcoming Investor Conference Schedule Ahead of Phase 2 Drilling at Sombrero
-
INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027
-
Life Time Makes it Easier for Members to Find Competitive Matches with DUPR In-App Integration
-
DeepSeek's Latest Update Scores Lower on Accounting Work as Open Models Trail on Consistency, DualEntry Benchmark Finds.
-
Building the Ultimate Game Night: Domino's® and Minecraft Dungeons II Team Up for a Block-Shaped Collaboration
-
VapeExpress Australia Offers Online Access to Vapes, E-Liquids and Vaping Accessories
-
Karpo Launches Karpo Browser and VibePad to Turn a Mood Into a Booked Night Out in One App
-
Trimble Third Quarter Earnings Call and Webcast
-
Extreme Agent ONE Coworker Saves Customers 1,000 Hours in First Month of Availability
-
PRG Real Estate's Dana Dobrowolski Named First Runner-Up in Grace Hill's 2026 Impact Hero Awards
-
Nanoscope Therapeutics Announces Publication of Preclinical Data Showing Targeted, Durable Vision Restoration with OCT-Guided, Non-Viral Gene Delivery
-
Extreme Previews Industry’s First On-Prem Enterprise AI Infrastructure for Networking
-
Elucid Announces FDA Clearance of FFR-IQ™ and Commercial Availability of the Most Accurate¹ FFR-CT Software
-
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027
-
WISDOMTREE WTI CRUDE OIL 3X DAILY SHORT SECURITIES ISIN: XS2819844387 PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES MEETING OF THE ETP SECURITYHOLDERS
-
SAFE Structure Designs Awarded Contract for Custom CH-47 Wraparound Maintenance Platforms for Minnesota Army National Guard
-
Natuzzi Announces Financial Results for the Second Quarter of 2026
-
Austin Roofing Awarded Major Steel Roof Restoration at Parts Canada Corporate Headquarters in London, Ontario
-
TNL Mediagene Announces $6.25 Million Strategic Investment from Vector Advisory Partners and Anticipated Change of Control Transaction
-
California Nanotechnologies Announces Amended Lease to Expand Santa Ana Manufacturing Facility Capacity
-
Lavras Gold Approves Fourth Diamond Drill Rig to Fast-Track Cerrito North Drill Testing; Fazenda-Butia LP Application Remains on Track
-
Endurance Expands Imperial and Lower Imperial Zones with 50 m Step Outs 5.89 gpt Gold and 0.19% Sb over 5.2 Metres & Multiple High-Grade Structures
-
Form 8.3 - Brave Bison Group Plc
-
Good Purpose Investments Announces Partnership Between Clario, Its Environmental Intelligence Subsidiary, and Bureau Veritas
-
New Days on the Roof of the World: Four Elders on 75 Years of Change in Xizang
-
Global Deep-Sea Scientific and Technological Innovation Forces to Gather in Hainan, China
-
Syntax and iRebal® from Schwab Advisor Services Team Up to Offer Advanced Personalized Indexing Services
-
Tom Sowden's New Memoir, So, the Boy Got Stronger, Chronicles a Life That Refused to Be Defined by the Odds
-
Fidelity D & D Bancorp, Inc. Reports Third Quarter 2026 Financial Results
-
First Canadian Graphite Inc. Announces $3M Financing
-
North Sky Metals Commences Trading on the TSX Venture Exchange Under Symbol "NSKY"
-
Strategic Metals Grants Incentive Stock Options
-
Rocky Shore Gold Engages Independent Trading Group as Market Maker
-
Pine Tree Acquisition Corp. Announces Separate Trading of Class A Ordinary Shares and Rights
-
Dispatch Launches MCP Server, Connecting AI Assistants Directly to Deliveries
-
Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026
-
Labrador Gold Announces Extension of Non-Brokered Private Placement
-
Stifel Reports Third Quarter 2026 Results
-
Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness
-
Sundance Biosciences Announces Presentation of Phase 1 Results for SUN-627, a Brain-Penetrant TYK2 Inhibitor for the Treatment of Multiple Sclerosis (MS)
-
BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE
-
Xali Gold Completes FTA Application for Drilling and Outlines Development Team for Pico Machay
-
Winnebago Industries Reports Fourth Quarter and Full Year Fiscal 2026 Results
-
The Authority™ Introduces Industry's First Universal Public Grading Standard for Collectibles
-
Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
